NZ223598A - Zinc-protamine-alpha interferon complexes and pharmaceutical compositions - Google Patents
Zinc-protamine-alpha interferon complexes and pharmaceutical compositionsInfo
- Publication number
- NZ223598A NZ223598A NZ223598A NZ22359888A NZ223598A NZ 223598 A NZ223598 A NZ 223598A NZ 223598 A NZ223598 A NZ 223598A NZ 22359888 A NZ22359888 A NZ 22359888A NZ 223598 A NZ223598 A NZ 223598A
- Authority
- NZ
- New Zealand
- Prior art keywords
- protamine
- alpha interferon
- zinc
- pharmaceutical compositions
- interferon complexes
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000006992 Interferon-alpha Human genes 0.000 abstract 2
- 108010047761 Interferon-alpha Proteins 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 1
- 229940048914 protamine Drugs 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/018,243 US4853218A (en) | 1987-02-24 | 1987-02-24 | Zinc-protamine-alpha interferon complex |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ223598A true NZ223598A (en) | 1989-12-21 |
Family
ID=21786960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ223598A NZ223598A (en) | 1987-02-24 | 1988-02-23 | Zinc-protamine-alpha interferon complexes and pharmaceutical compositions |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4853218A (enExample) |
| EP (2) | EP0281299B1 (enExample) |
| JP (1) | JPH0611712B2 (enExample) |
| KR (1) | KR940001372B1 (enExample) |
| AT (1) | ATE76580T1 (enExample) |
| AU (1) | AU608584B2 (enExample) |
| CA (1) | CA1316105C (enExample) |
| DE (1) | DE3871407D1 (enExample) |
| DK (1) | DK167048B1 (enExample) |
| ES (1) | ES2032009T3 (enExample) |
| FI (1) | FI93309C (enExample) |
| GR (1) | GR3005358T3 (enExample) |
| HU (1) | HU201881B (enExample) |
| IE (1) | IE61340B1 (enExample) |
| IL (1) | IL85523A (enExample) |
| MX (1) | MX9203328A (enExample) |
| MY (1) | MY103212A (enExample) |
| NO (1) | NO173279C (enExample) |
| NZ (1) | NZ223598A (enExample) |
| OA (1) | OA09737A (enExample) |
| PT (1) | PT86810B (enExample) |
| WO (1) | WO1988006456A1 (enExample) |
| ZA (1) | ZA881258B (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028422A (en) * | 1986-05-27 | 1991-07-02 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
| DK264787A (da) * | 1986-05-27 | 1987-11-28 | Schering Corp | Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat |
| ATE90205T1 (de) * | 1987-09-08 | 1993-06-15 | Takeda Chemical Industries Ltd | Wasserunloesliche cytokine. |
| CA2084406A1 (en) * | 1990-06-04 | 1991-12-05 | Paul Reichert | Method for preparing interferon alpha-2 crystals |
| US5912015A (en) | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
| US5711968A (en) * | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
| US6514533B1 (en) | 1992-06-11 | 2003-02-04 | Alkermas Controlled Therapeutics, Inc. | Device for the sustained release of aggregation-stabilized, biologically active agent |
| EP1013270A3 (en) * | 1992-12-02 | 2001-03-28 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
| US5441734A (en) * | 1993-02-25 | 1995-08-15 | Schering Corporation | Metal-interferon-alpha crystals |
| US6087324A (en) * | 1993-06-24 | 2000-07-11 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| AU706180B2 (en) * | 1994-07-25 | 1999-06-10 | Alkermes Controlled Therapeutics, Inc. | Controlled release of metal cation-stabilized interferon |
| US5904935A (en) * | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
| JP3837769B2 (ja) * | 1995-06-12 | 2006-10-25 | 大塚製薬株式会社 | 抗ウイルス剤 |
| WO1997007788A2 (en) * | 1995-08-31 | 1997-03-06 | Alkermes Controlled Therapeutics, Inc. | Composition for sustained release of an agent |
| CN1146402C (zh) * | 1996-12-20 | 2004-04-21 | 阿尔萨公司 | 凝胶组合物及方法 |
| US6465425B1 (en) | 2000-02-10 | 2002-10-15 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins |
| US20030211974A1 (en) * | 2000-03-21 | 2003-11-13 | Brodbeck Kevin J. | Gel composition and methods |
| CA2466632C (en) * | 2001-11-14 | 2014-02-11 | Alza Corporation | Injectable depot compositions and uses thereof |
| US20070196415A1 (en) * | 2002-11-14 | 2007-08-23 | Guohua Chen | Depot compositions with multiple drug release rate controls and uses thereof |
| AU2002359407B2 (en) * | 2001-11-14 | 2008-02-28 | Durect Corporation | Catheter injectable depot compositions and uses thereof |
| CA2466642C (en) * | 2001-11-14 | 2011-01-18 | Guohua Chen | Injectable depot composition |
| TWI353854B (en) | 2002-06-25 | 2011-12-11 | Alza Corp | Short duration depot formulations |
| US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| ES2319400T3 (es) * | 2002-07-31 | 2009-05-07 | Durect Corporation | Composiciones deposito inyectables y empleo de las mismas. |
| ATE419831T1 (de) | 2002-07-31 | 2009-01-15 | Alza Corp | Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen |
| DE60325511D1 (de) * | 2002-11-06 | 2009-02-05 | Alza Corp | Depot-formulierungen mit verzögerter freisetzung |
| WO2004060920A1 (en) * | 2002-12-31 | 2004-07-22 | Altus Pharmaceuticals Inc. | Complexes of protein crystals and ionic polymers |
| JP4686361B2 (ja) * | 2002-12-31 | 2011-05-25 | アルタス ファーマシューティカルズ インコーポレイテッド | ヒト成長ホルモンの結晶およびその調製方法 |
| CN1822816A (zh) * | 2003-05-30 | 2006-08-23 | 阿尔萨公司 | 可植入的弹性体储库组合物、其用途以及制备方法 |
| US20070184084A1 (en) * | 2003-05-30 | 2007-08-09 | Guohua Chen | Implantable elastomeric caprolactone depot compositions and uses thereof |
| US20050106214A1 (en) * | 2003-11-14 | 2005-05-19 | Guohua Chen | Excipients in drug delivery vehicles |
| US20050281879A1 (en) * | 2003-11-14 | 2005-12-22 | Guohua Chen | Excipients in drug delivery vehicles |
| US7812049B2 (en) * | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| US20060142234A1 (en) * | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension |
| JP2009521486A (ja) * | 2005-12-23 | 2009-06-04 | アルタス ファーマシューティカルズ インコーポレイテッド | ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法 |
| US7753077B2 (en) | 2007-04-19 | 2010-07-13 | Husco International Inc. | Hybrid hydraulic joystick for electrically operating valves |
| US7753078B2 (en) | 2007-04-19 | 2010-07-13 | Husco International Inc. | Hybrid hydraulic joystick with an integral pressure sensor and an outlet port |
| JP4889782B2 (ja) * | 2008-12-24 | 2012-03-07 | 株式会社マルハニチロ食品 | プロタミン及び／またはその塩と酸性高分子化合物とを含む生理活性複合体及びその用途 |
| NZ594248A (en) * | 2009-01-28 | 2015-03-27 | Smartcells Inc | Conjugate based systems for controlled drug delivery |
| EA026964B1 (ru) * | 2010-11-24 | 2017-06-30 | Дьюрект Корпорейшн | Биоразлагаемая композиция для доставки лекарственного средства (варианты) |
| WO2015088990A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
| BR112022013784A2 (pt) | 2020-01-13 | 2022-10-11 | Durect Corp | Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados |
| KR20230145053A (ko) | 2021-01-12 | 2023-10-17 | 듀렉트 코퍼레이션 | 지속 방출 약물 전달 시스템 및 관련 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1282504A (fr) * | 1954-06-03 | 1962-01-27 | Novo Terapeutisk Labor As | Procédé de production de suspensions stables d'insuline zinc-protamine |
| US3912807A (en) * | 1974-04-18 | 1975-10-14 | American Home Prod | Treatment of diabetes using somatostatin and insulin |
| IN150740B (enExample) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
| PH21848A (en) * | 1980-01-08 | 1988-03-17 | Biogen Nv | Dna sequences and recombinant dna molecules |
| ES506955A0 (es) * | 1980-11-10 | 1983-02-01 | Genentech Inc | Un procedimiento para producir un polipeptido antiviral. |
| DE3262575D1 (en) * | 1981-12-23 | 1985-04-18 | Schering Corp | Stabilised interferon formulations and their preparation |
| US4605555A (en) * | 1984-09-20 | 1986-08-12 | Sun Star Kabushiki Kaisha | Composition and method for treating keratosic disorder of skin and mucosa |
-
1987
- 1987-02-24 US US07/018,243 patent/US4853218A/en not_active Expired - Fee Related
-
1988
- 1988-02-19 MY MYPI88000169A patent/MY103212A/en unknown
- 1988-02-23 EP EP88301500A patent/EP0281299B1/en not_active Expired - Lifetime
- 1988-02-23 AT AT88301500T patent/ATE76580T1/de active
- 1988-02-23 EP EP88902309A patent/EP0375678A1/en active Pending
- 1988-02-23 HU HU881926A patent/HU201881B/hu not_active IP Right Cessation
- 1988-02-23 DE DE8888301500T patent/DE3871407D1/de not_active Expired - Lifetime
- 1988-02-23 PT PT86810A patent/PT86810B/pt not_active IP Right Cessation
- 1988-02-23 AU AU13946/88A patent/AU608584B2/en not_active Ceased
- 1988-02-23 ZA ZA881258A patent/ZA881258B/xx unknown
- 1988-02-23 ES ES198888301500T patent/ES2032009T3/es not_active Expired - Lifetime
- 1988-02-23 CA CA000559620A patent/CA1316105C/en not_active Expired - Fee Related
- 1988-02-23 IE IE48088A patent/IE61340B1/en not_active IP Right Cessation
- 1988-02-23 NZ NZ223598A patent/NZ223598A/xx unknown
- 1988-02-23 JP JP63502283A patent/JPH0611712B2/ja not_active Expired - Lifetime
- 1988-02-23 WO PCT/US1988/000410 patent/WO1988006456A1/en not_active Ceased
- 1988-02-23 KR KR1019880701321A patent/KR940001372B1/ko not_active Expired - Fee Related
- 1988-02-23 IL IL85523A patent/IL85523A/xx not_active IP Right Cessation
- 1988-10-14 NO NO884596A patent/NO173279C/no unknown
- 1988-10-19 DK DK582188A patent/DK167048B1/da not_active IP Right Cessation
-
1989
- 1989-08-22 FI FI893929A patent/FI93309C/fi not_active IP Right Cessation
- 1989-08-24 OA OA59633A patent/OA09737A/en unknown
-
1992
- 1992-06-25 MX MX9203328A patent/MX9203328A/es unknown
- 1992-08-06 GR GR920401691T patent/GR3005358T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ223598A (en) | Zinc-protamine-alpha interferon complexes and pharmaceutical compositions | |
| NZ224903A (en) | C-terminal alpha aminoboronic acid derivatives and pharmaceutical compositions | |
| IL102848A0 (en) | Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them | |
| IL91706A (en) | Pharmaceutical compositions comprising in separate dosage form a plasminogen activator and hirudin | |
| NZ223630A (en) | Insulin derivative and pharmaceutical compositions | |
| IL76932A0 (en) | Pharmaceutical compositions containing dihydrocodeine and ibuprofen | |
| GR3001185T3 (en) | Stable solid pharmaceutical composition containing ibuprofen and codeine | |
| IL68456A0 (en) | Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles | |
| ZA881053B (en) | Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration | |
| ATE67783T1 (de) | Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen. | |
| GR3002765T3 (en) | New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient | |
| EP0295559A3 (en) | Pharmaceutical composition for the treatment of tumors | |
| DE3766885D1 (en) | Chlorpheniramine therapie. | |
| GR3006999T3 (enExample) | ||
| EP0468327A3 (en) | Oral pharmaceutical compositions containing hirudin | |
| EP0127389A3 (en) | N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor | |
| ES2016052A6 (es) | Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico. | |
| ATE102934T1 (de) | Fluorierte flavon-essigsaeure. | |
| IL87867A0 (en) | Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives | |
| AU609435B2 (en) | Prevention of bovine respiratory disease complex in cattle by administration of interferon | |
| GB8718805D0 (en) | Article for administering medicine | |
| ZA879325B (en) | Prevention of bovine respiratory disease complex in cattle by administration of interferon |